SARS‐CoV‐2 variants and vulnerability at the global level

VP Chavda, AB Patel… - Journal of medical …, 2022 - Wiley Online Library
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …

A global overview of dietary supplements: regulation, market trends, usage during the COVID-19 pandemic, and health effects

O Djaoudene, A Romano, YD Bradai, F Zebiri… - Nutrients, 2023 - mdpi.com
Over the last 20 years, the use of dietary supplements (DS) has continued to grow in many
countries. Due to the public health crisis brought on by the COVID-19 pandemic and amidst …

Recent review of COVID-19 management: Diagnosis, treatment and vaccination

VP Chavda, S Vuppu, T Mishra, S Kamaraj… - Pharmacological …, 2022 - Springer
The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …

mRNA-based vaccines and therapeutics for COVID-19 and future pandemics

VP Chavda, S Soni, LK Vora, S Soni, A Khadela… - Vaccines, 2022 - mdpi.com
An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been
sparked by the COVID-19 pandemic. Two years ago, COVID-19's launch propelled mRNA …

Therapeutic monoclonal antibodies for COVID-19 management: an update

VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …

Replicating viral vector-based vaccines for COVID-19: potential avenue in vaccination arena

VP Chavda, R Bezbaruah, M Athalye, PK Parikh… - Viruses, 2022 - mdpi.com
The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …

COVID-19 and vaccination: myths vs science

VP Chavda, Y Chen, J Dave, ZS Chen… - Expert Review of …, 2022 - Taylor & Francis
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …

Conventional and novel diagnostic tools for the diagnosis of emerging SARS-CoV-2 variants

VP Chavda, DD Valu, PK Parikh, N Tiwari, AS Chhipa… - Vaccines, 2023 - mdpi.com
Accurate identification at an early stage of infection is critical for effective care of any
infectious disease. The “coronavirus disease 2019 (COVID-19)” outbreak, caused by the …

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update

VP Chavda, R Bezbaruah, S Dolia, N Shah… - Process …, 2023 - Elsevier
The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific and …

Are nutraceuticals effective in COVID-19 and post-COVID prevention and treatment?

A Catalano, D Iacopetta, J Ceramella, ACD Maio… - Foods, 2022 - mdpi.com
The beginning of the end or the end of the beginning? After two years mastered by
coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The …